Skip to main content

Table 3 Peptides synthesized for in vitro analysis.a

From: Peptides That Bind Specifically to an Antibody from a Chronic Lymphocytic Leukemia Clone Expressing Unmutated Immunoglobulin Variable Region Genes

Peptidea

Sequence

K D b

Selection target (comment)

D4-Btn

DYCNLSVSWCYP-K (Btn)

ND

U-CLL mAb 068 (this work; family 2)

D4-3K

DYCNLSVSWCYP-GSGKKK

NB

D2-Btn

VSCNPFSWLPRCYA-K (Btn)

ND

U-CLL mAb 068 (this work; family 5)

D2-3K

VSCNPFSWLPRCYA-GSGKKK

58 µmol/L

E6-Btn

FPCWALPSQYLCRP-K (Btn)

ND

U-CLL mAb 068 (this work)

E6-3K

FPCWALPSQYLCRP-GSGKKK

111 µmol/L

PhD-068-4-Btn

WPLWSIPPFSPR-K (Btn)

weak

U-CLL mAb 068 (reference [5])

PhD-068-4-3K

WPLWSIPPFSPR-KKKK

weak

PhD-169-8-Btn

DNYAAALAQRAR-K (Btn)

ND

M-CLL mAb 169 (reference [5])

PhD-169-8-4K

DNYAAALAQRAR-KKKK

31 nmol/L

  1. aAll peptides synthesized as C-terminal amides.
  2. bND, not determined; NB, no binding.